Replies to post #86479 on PharmaCyte Biotech Inc (PMCB)

[oldmusky]

I feel and have always felt that an excepted IND is the tipping point. We will get there in time and when that happens outside money will come rushing in. Until then, it is a slog to the IND.

There are companies that file INDs and the response they get from the FDA is to do a battery of tests that takes a very long time. PMCB is trying to file an IND that will get accepted, thus all the tests.